to join the discussion
NVS trading at R541 after today's 1.81% pullback warrants scrutiny against Distell, which commands a premium despite similar distribution challenges and exposure to mature categories. The question isn't whether Novus is cheaper, but whether its balance sheet leverage and capital
At R540 I reckon NVS needs to show they can actually grow volumes instead of just hiking prices to offset input costs. The retail environment isn't getting easier and their margin story only holds if consumers keep swallowing price increases.
NVS up 0.93% to R540 but the retail headwinds aren't easing. Question is whether this bounce holds or we see another test of support.
NVS down 7% today to R530 - is this a panic sell from retail or are institutional investors seeing cracks in the Dis-Chem growth story? Anyone digging into what triggered this?